| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |